Dendrimer therapeutics: covalent and ionic attachments
- 8 September 2011
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 36 (2) , 227-240
Abstract
This concise review focuses on dendrimers functionalized by different linkers required for covalent and ionic attachments of drugs to the dendrimer's surface and highlights the importance of the chemical nature of linkers for controlled release of free drugs. The stability of linkers under physiological conditions and their lability under acidic conditions such as those of endosomes and lysosomes or under enzymatic conditions will be discussed. Especially, we review functionality of the most recently reported drug–dendrimer conjugates. Then, we give a short comparison of dendrimer conjugates versus either dendrimer complexes or polymer therapeutics and finally we briefly summarize the importance of both targeted and nontargeted covalently conjugated drugs.Keywords
This publication has 90 references indexed in Scilit:
- Polyvalent saccharide-functionalized generation 3 poly(amidoamine) dendrimer–methotrexate conjugate as a potential anticancer agentBioorganic & Medicinal Chemistry, 2011
- Chemotherapeutic Evaluation of a Synthetic Tubulysin Analogue–Dendrimer Conjugate in C26 Tumor Bearing MiceChemMedChem, 2010
- GPCR ligand–dendrimer (GLiDe) conjugates: future smart drugs?Trends in Pharmacological Sciences, 2010
- pH-Responsive Nanoparticles for Drug DeliveryMolecular Pharmaceutics, 2010
- Design of riboflavin-presenting PAMAM dendrimers as a new nanoplatform for cancer-targeted deliveryBioorganic & Medicinal Chemistry Letters, 2010
- Amino Acid-Functionalized Dendrimers with Heterobifunctional Chemoselective Peripheral Groups for Drug Delivery ApplicationsBiomacromolecules, 2010
- Targeted Dendrimeric Anticancer Prodrug: A Methotrexate-Folic Acid-Poly(amidoamine) Conjugate and a Novel, Rapid, “One Pot” Synthetic ApproachBioconjugate Chemistry, 2010
- Effects of Branching Architecture and Linker on the Activity of Hyperbranched Polymer−Drug ConjugatesBioconjugate Chemistry, 2009
- Dendrimer−Drug Conjugates for Tailored Intracellular Drug Release Based on Glutathione LevelsBioconjugate Chemistry, 2008
- Attenuation of β-amyloid-induced toxicity by sialic-acid-conjugated dendrimers: Role of sialic acid attachmentBrain Research, 2007